These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 17572700)

  • 1. Chronic endothelin-A receptor antagonism is as protective as angiotensin converting enzyme inhibition against cardiac dysfunction in diabetic rats.
    Wölkart G; Pang X; Stessel H; Kirchengast M; Brunner F
    Br J Pharmacol; 2007 Aug; 151(8):1187-97. PubMed ID: 17572700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ACE-inhibition is superior to endothelin A receptor blockade in preventing abnormal capillary supply and fibrosis of the heart in experimental diabetes.
    Gross ML; Heiss N; Weckbach M; Hansen A; El-Shakmak A; Szabo A; Münter K; Ritz E; Amann K
    Diabetologia; 2004 Feb; 47(2):316-24. PubMed ID: 14727024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardioprotective effects of atrasentan, an endothelin-A receptor antagonist, but not of nitric oxide in diabetic mice with myocyte-specific overexpression of endothelial nitric oxide synthase.
    Wölkart G; Stessel H; Saad Z; Kirchengast M; Brunner F
    Br J Pharmacol; 2006 Jul; 148(5):671-81. PubMed ID: 16702986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of myocardial nitric oxide in diabetic ischemia-reperfusion dysfunction: studies in mice with myocyte-specific overexpression of endothelial nitric-oxide synthase.
    Pozo-Navas B; Stessel H; Wölkart G; Brunner F
    J Pharmacol Exp Ther; 2006 Nov; 319(2):729-38. PubMed ID: 16857730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postischemic antiarrhythmic effects of angiotensin-converting enzyme inhibitors. Role of suppression of endogenous endothelin secretion.
    Brunner F; Kukovetz WR
    Circulation; 1996 Oct; 94(7):1752-61. PubMed ID: 8840871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of ET(A) and ET(B) receptor blockade on post-ischemic cardiac dysfunction and norepinephrine overflow in isolated rat hearts.
    Yamamoto S; Matsumoto N; Kanazawa M; Fujita M; Takaoka M; Matsumura Y
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S394-7. PubMed ID: 15838330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of myocardial fibrosis by N-acetyl-seryl-aspartyl-lysyl-proline in diabetic rats.
    Castoldi G; di Gioia CR; Bombardi C; Perego C; Perego L; Mancini M; Leopizzi M; Corradi B; Perlini S; Zerbini G; Stella A
    Clin Sci (Lond); 2009 Oct; 118(3):211-20. PubMed ID: 20310083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II and endothelin-1 augment the vascular complications of diabetes via JAK2 activation.
    Banes-Berceli AK; Ketsawatsomkron P; Ogbi S; Patel B; Pollock DM; Marrero MB
    Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H1291-9. PubMed ID: 17526654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined inhibition of neutral endopeptidase with angiotensin converting enzyme or endothelin converting enzyme in experimental diabetes.
    Tikkanen I; Tikkanen T; Cao Z; Allen TJ; Davis BJ; Lassila M; Casley D; Johnston CI; Burrell LM; Cooper ME
    J Hypertens; 2002 Apr; 20(4):707-14. PubMed ID: 11910307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance imaging analysis of cardiac cycle events in diabetic rats: the effect of angiotensin-converting enzyme inhibition.
    Al-Shafei AI; Wise RG; Gresham GA; Carpenter TA; Hall LD; Huang CL
    J Physiol; 2002 Jan; 538(Pt 2):555-72. PubMed ID: 11790819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular hypertrophy and albumin permeability in a rat model combining hypertension and diabetes mellitus. Effects of calcium antagonism, angiotensin converting enzyme inhibition, and angiotensin II-AT1-receptor blockade.
    Hulthén UL; Cao Z; Rumble JR; Cooper ME; Johnston CI
    Am J Hypertens; 1996 Sep; 9(9):895-901. PubMed ID: 8879346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of losartan, ramipril and their combination on left ventricular remodeling and function in spontaneous hypertensive rats].
    Xu R; Zhang Y; Zhang M; Li XC; Cai H; Chen WQ; Zhu H; Ge ZM; Zhang W
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(45):3199-204. PubMed ID: 16405840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACE inhibition decreases postoperative mortality in rats with left ventricular hypertrophy and myocardial infarction.
    Linz W; Wiemer G; Schmidts HL; Ulmer W; Ruppert D; Schölkens BA
    Clin Exp Hypertens; 1996 Jul; 18(5):691-712. PubMed ID: 8781754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preservation of left ventricular function and coronary flow by angiotensin I-converting enzyme inhibition in the hypertensive-diabetic Dahl rat.
    Given MB; Lowe RF; Gelvin CR; Sander GE; Giles TD
    Am J Hypertens; 1994 Oct; 7(10 Pt 1):919-25. PubMed ID: 7826556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal damage in the SHR/N-cp type 2 diabetes model: comparison of an angiotensin-converting enzyme inhibitor and endothelin receptor blocker.
    Gross ML; Ritz E; Schoof A; Helmke B; Parkman A; Tulp O; Münter K; Amann K
    Lab Invest; 2003 Sep; 83(9):1267-77. PubMed ID: 13679434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ACE-I on diabetic cardiovascular complications: anti-hypertensive and non-antihypertensive doses.
    Udayachalerm W; Vechakarn O; Patumraj S
    J Med Assoc Thai; 2001 Jun; 84 Suppl 1():S306-13. PubMed ID: 11529349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of exogenous big endothelin-1 on postischemic cardiac dysfunction and norepinephrine overflow in rat hearts.
    Tawa M; Fukumoto T; Ohkita M; Yamashita N; Geddawy A; Imamura T; Ayajiki K; Okamura T; Matsumura Y
    Hypertens Res; 2011 Feb; 34(2):218-24. PubMed ID: 21048781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardioprotection with angiotensin converting enzyme inhibitor and angiotensin II type 1 receptor antagonist is not abolished by nitric oxide synthase inhibitor in ischemia-reperfused rabbit hearts.
    Kawabata H; Ryomoto T; Ishikawa K
    Hypertens Res; 2001 Jul; 24(4):403-9. PubMed ID: 11510753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic kidney disease: cardiac and renal angiotensin-converting enzyme (ACE) 2 expression in rats after subtotal nephrectomy and the effect of ACE inhibition.
    Burrell LM; Burchill L; Dean RG; Griggs K; Patel SK; Velkoska E
    Exp Physiol; 2012 Apr; 97(4):477-85. PubMed ID: 22198016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACE-inhibitors but not endothelin receptor blockers prevent podocyte loss in early diabetic nephropathy.
    Gross ML; El-Shakmak A; Szábó A; Koch A; Kuhlmann A; Münter K; Ritz E; Amann K
    Diabetologia; 2003 Jun; 46(6):856-68. PubMed ID: 12802493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.